Related Experiment Videos
Symptomatic and disease-modifying therapy for the progressive ataxias
1David Geffen School of Medicine at the University of California, Los Angeles 90095, USA. sperlman@ucla.edu
The Neurologist
|September 1, 2004
Summary
Progressive ataxias are neurological disorders affecting the cerebellum. While no FDA-approved disease-modifying therapies exist, symptomatic treatments and rehabilitation significantly enhance patient quality of life.
Area of Science:
- Neuroscience
- Neurology
Background:
- Progressive ataxias encompass diverse neurological diseases characterized by cerebellar degeneration.
- These conditions vary in cause, progression, and involvement of non-cerebellar systems.
- The underlying pathophysiology remains incompletely understood for most cases.
Purpose of the Study:
- To outline current and potential treatment strategies for progressive ataxias.
- To inform clinical decision-making regarding unproven or complementary therapies.
Main Methods:
- Review of existing treatment approaches for progressive ataxias.
- Discussion of symptomatic management, rehabilitation, and supportive care.
Main Results:
- No Food and Drug Administration-approved drugs are currently available for progressive ataxias.
- Few disease-modifying therapies exist for these neurodegenerative disorders.
Conclusions:
- Symptomatic treatments and rehabilitation interventions are crucial for improving quality of life in patients with progressive ataxias.
- Clinical management focuses on supportive care and addressing complications in the absence of definitive cures.